Target Price | €32.74 |
Price | €26.40 |
Potential | 24.02% |
Number of Estimates | 5 |
5 Analysts have issued a price target Lenzing 2026 . The average Lenzing target price is €32.74. This is 24.02% higher than the current stock price. The highest price target is €35.00 32.58% , the lowest is €28.00 6.06% . | |
A rating was issued by 5 analysts: 0 Analysts recommend Lenzing to buy, 5 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Lenzing stock has an average upside potential 2026 of 24.02% . Most analysts recommend the Lenzing stock at Hold. |
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Billion € | 2.66 | 2.83 |
5.66% | 6.39% | |
EBITDA Margin | 4.54% | 15.78% |
25.11% | 247.87% | |
Net Margin | -5.88% | -0.91% |
77.18% | 84.52% |
5 Analysts have issued a sales forecast Lenzing 2025 . The average Lenzing sales estimate is €2.8b . This is 5.14% higher than the revenue of the last 12 months(TTM). The highest sales forecast is €3.3b 22.38% , the lowest is €2.7b 1.29% .
This results in the following potential growth metrics:
2024 | €2.7b | 5.66% |
---|---|---|
2025 | €2.8b | 6.39% |
2026 | €2.9b | 3.27% |
2027 | €2.9b | 1.32% |
2028 | €3.0b | 3.46% |
5 Analysts have issued an Lenzing EBITDA forecast 2025. The average Lenzing EBITDA estimate is €447m . This is 7.22% lower than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is €461m 4.37% , the lowest is €407m 15.50% .
This results in the following potential growth metrics and future EBITDA Margins:
2024 | €121m | 32.20% |
---|---|---|
2025 | €447m | 270.14% |
2026 | €504m | 12.65% |
2027 | €529m | 5.05% |
2028 | €595m | 12.41% |
2024 | 4.54% | 25.11% |
---|---|---|
2025 | 15.78% | 247.87% |
2026 | 17.22% | 9.13% |
2027 | 18.33% | 6.45% |
2028 | 19.91% | 8.62% |
5 Lenzing Analysts have issued a net profit forecast 2025. The average Lenzing net profit estimate is €-25.8m . This is 78.49% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is €8.5m 107.09% , the lowest is €-67.5m 43.69% .
This results in the following potential growth metrics and future Net Margins:
2024 | €-157m | 75.89% |
---|---|---|
2025 | €-25.8m | 83.53% |
2026 | €31.8m | 223.26% |
2027 | €44.3m | 39.19% |
2028 | €91.9m | 107.73% |
2024 | -5.88% | 77.18% |
---|---|---|
2025 | -0.91% | 84.52% |
2026 | 1.09% | 219.78% |
2027 | 1.53% | 40.37% |
2028 | 3.08% | 101.31% |
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share € | -4.06 | -0.67 |
79.72% | 83.50% | |
P/E | negative | |
EV/Sales | 0.95 |
5 Analysts have issued a Lenzing forecast for earnings per share. The average Lenzing EPS is €-0.67 . This is 78.10% higher than earnings per share in the financial year 2024. The highest EPS forecast is €0.22 107.19% , the lowest is €-1.75 42.81% .
This results in the following potential growth metrics and future valuations:
2024 | €-4.06 | 79.72% |
---|---|---|
2025 | €-0.67 | 83.50% |
2026 | €0.82 | 222.39% |
2027 | €1.15 | 40.24% |
2028 | €2.38 | 106.96% |
Current | -8.63 | 292.46% |
---|---|---|
2025 | -39.54 | 358.30% |
2026 | 32.07 | 181.11% |
2027 | 23.04 | 28.16% |
2028 | 11.09 | 51.87% |
Based on analysts' sales estimates for 2025, the Lenzing stock is valued at an EV/Sales of 0.95 and an P/S ratio of 0.37 .
This results in the following potential growth metrics and future valuations:
Current | 1.00 | 13.79% |
---|---|---|
2025 | 0.95 | 4.81% |
2026 | 0.92 | 3.16% |
2027 | 0.93 | 1.33% |
2028 | 0.90 | 3.34% |
Current | 0.39 | 24.64% |
---|---|---|
2025 | 0.37 | 4.87% |
2026 | 0.36 | 3.18% |
2027 | 0.36 | 1.34% |
2028 | 0.35 | 3.33% |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.